Creative Antibiotics AB (OSTO:CAS) EV-to-EBIT : -18.81 (As of Sep. 24, 2024)

View and export this data going back to . Start your Free Trial

What is Creative Antibiotics AB EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Creative Antibiotics AB's Enterprise Value is kr205.86 Mil. Creative Antibiotics AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2013 was kr-10.94 Mil. Therefore, Creative Antibiotics AB's EV-to-EBIT for today is -18.81.

The historical rank and industry rank for Creative Antibiotics AB's EV-to-EBIT or its related term are showing as below:

OSTO:CAS's EV-to-EBIT is not ranked ^*
in the industry.
Industry Median:
* Ranked among companies with meaningful EV-to-EBIT only.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Creative Antibiotics AB's Enterprise Value for the quarter that ended in Mar. 2013 was kr0.00 Mil. Creative Antibiotics AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2013 was kr-10.94 Mil. Creative Antibiotics AB's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2013 was %.

Creative Antibiotics AB EV-to-EBIT Historical Data

The historical data trend for Creative Antibiotics AB's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Creative Antibiotics AB EV-to-EBIT Chart

Creative Antibiotics AB Annual Data

Trend

Jun08

Jun09

Jun10

Dec11

EV-to-EBIT

Creative Antibiotics AB Quarterly Data
	Jun08	Mar09	Jun09	Sep09	Dec09	Mar10	Sep10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Mar13
EV-to-EBIT	Get a 7-Day Free Trial										-	-	-	-	-

Competitive Comparison of Creative Antibiotics AB's EV-to-EBIT

For the subindustry, Creative Antibiotics AB's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Creative Antibiotics AB's EV-to-EBIT Distribution in the Industry

For the industry and sector, Creative Antibiotics AB's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Creative Antibiotics AB's EV-to-EBIT falls into.

Creative Antibiotics AB EV-to-EBIT Calculation

Creative Antibiotics AB's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	205.864	/	-10.944
	=	-18.81

Creative Antibiotics AB's current Enterprise Value is kr205.86 Mil.
Creative Antibiotics AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2013 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-10.94 Mil.

Creative Antibiotics AB (OSTO:CAS) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Creative Antibiotics AB's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2013 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2013 )	=	EBIT	/	Enterprise Value (Q: Mar. 2013 )
	=	-10.944	/	0
	=	%

Creative Antibiotics AB's Enterprise Value for the quarter that ended in Mar. 2013 was kr0.00 Mil.
Creative Antibiotics AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2013 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-10.94 Mil.

Creative Antibiotics AB EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Creative Antibiotics AB's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.